Medication for weight loss has gained more attention than ever in the last 12 months. Originally created to treat type 2 diabetes, medications have swiftly become well-known due to celebrity endorsements and viral social media posts. The need for research is as great as the demand, particularly to make sure that these treatments are safe and effective for a variety of populations that suffer from obesity. We at Tribe Clinical Research have been leading this effort. Our group has enrolled patients with and without diabetes, those with cardiovascular disease, and people in a variety of BMI categories in more than 25 successful obesity trials.
The surge in popularity of medications like GLP-1 receptor agonists reflects a major shift in how obesity is viewed, not just as a lifestyle issue, but as a chronic medical condition that deserves evidence-based treatment. Clinical research ensures that new and existing therapies are studied in real-world patient populations.
Dr. Ronald Mayfield, Board Certified in Internal Medicine, Endocrinology, and Metabolism, has served as the Principal Investigator for 18 obesity studies and 9 diabetic obesity studies. He emphasizes:
“The excitement around new weight loss medications is justified, but it’s important to remember that research is what allows us to refine treatment, understand long-term safety, and expand access for the patients who need it most.”
Dr. Carole Mercer, Board Certified in Internal Medicine and Pediatrics and currently pursuing certification in Obesity Medicine, has also played a vital role in obesity research. She notes:
“Obesity is a complex disease, and no single solution works for everyone. Through our trials, we’re working to make sure future treatments reflect that reality—and give hope to the millions of patients seeking better options.”
By combining deep clinical experience with a commitment to diverse enrollment, Tribe Clinical Research ensures that every study contributes to a fuller picture of how weight loss medications can help real patients.
With obesity affecting nearly 42% of U.S. adults, the need for research has never been greater. Tribe Clinical Research is proud to be part of the solution, partnering with sponsors, providers, and patients to advance the science of obesity care.
Whether you’re a healthcare professional interested in clinical trials or a patient exploring your options, we invite you to learn more at TribeClinicalResearch.com.
